DNTH Competitors & Alternatives
Compare Dianthus Therapeutics Inc. with similar stocks in the same industry
Biotechnology
DNTH
Main Stock$88.32
Tradestie Score
67
Market Cap
$1.55B
Revenue Growth
2.9%
Analyst Upside
+59.4%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TGTX
TG Therapeutics, Inc.
|
$53.62
|
$5.80B | 20.4 | 51 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$325.31
|
$5.20B | 41.7 | 62 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$56.05
|
$4.94B | - | 52 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$64.13
|
$4.93B | - | 47 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$64.79
|
$4.84B | - | 68 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 50 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$139.19
|
$3.98B | 136.8 | 67 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$84.95
|
$3.92B | - | 46 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$110.12
|
$3.91B | - | 66 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$25.50
|
$3.83B | - | 49 | Compare |
More DNTH Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry